Skip Ribbon Commands Skip to main content
LFR a bacterium (MRSA, yellow) being ingested by an immune cell (Neutrophil, purple)LFR lung cancer cell during cell divisionMoores Cancer Center


Our revolutionary building brings together research, education, and clinical care under one roof. This allows clinicians and scientists to communicate more efficiently and advance patient care through translational research. From research in molecular genetics to the most advanced clinical treatments, Moores Cancer Center is at the forefront of the fight against cancer, developing promising new therapies and making them available to cancer patients throughout the region. Read More >

Pancreatic Cancer "Dream Team"

Andrew Lowy, MD, and Tannishtha Reya, PhD, have been recruited for their expertise in preclinical modeling, clinical trials, and stem cell biology to join a “dream team” of international pancreatic cancer researchers. The three-year, $12-million effort, sponsored by Stand Up To Cancer, Cancer Research UK, and The Lustgarten Foundation, will pursue a three-pronged strategy to better understand and reset so-called “super-enhancers” that may be abnormally active in pancreatic tumors. Super-enhancers are bits of DNA that can cause over-expression of genetic signals, fueling cancer cell growth. Read the full press release for more information.